The HHS, led by Robert F. Kennedy Jr. has decided to abandon development of mRNA vaccines, including a contract with Moderna for an avian flu vaccine, affecting 22 projects worth nearly $500 million. At the same time, researchers at the University of Florida have obtained promising results for an experimental mRNA vaccine that stimulates the immune system to fight cancer without targeting a specific protein. This suggests a new paradigm in the development of cancer vaccines, with the potential to offer innovative treatments for various types of tumors.
Sources
Departamentul Sănătăţii condus de Robert F. Kennedy jr. renunţă la finanţarea dezvoltării vaccinurilor cu tehnologia ARNm
US to halt $500M in vaccine projects
RFK Jr cancels $500m in mRNA vaccine development in the US
RFK Jr's health department to halt $500m in mRNA vaccine research
Robert Kennedy Jr, le ministre de la santé américain, bloque les financements pour les vaccins à ARN messager
RFK Jr. cuts $500 million in mRNA vaccine contracts
RFK Jr cancels $500M in vaccine development after ‘listening to the experts’
RFK Jr cancels $500 million in mRNA research, HHS to prioritize 'safer' vaccine alternatives
Departamentul Sănătăţii condus de Robert F. Kennedy jr. renunţă la finanţarea dezvoltării vaccinurilor cu tehnologia ARNm
Latest News
23:00
London authorities close traffic on Oxford Street: Britain’s busiest shopping street becomes pedestrian-only
22:55
Meta seeks to raise up to $95 billion to expand its artificial intelligence infrastructure
22:47
Audi CEO criticized in Germany after appearing alongside Trump / Gernot Döllner participated in the announcement of a $4.2 billion investment to build Audi’s first factory in the US
22:39
Kelemen Hunor estimates that the Luca Niculescu Government will remain in power until 2028: “If nobody brings you down, then you have no choice, you are condemned to govern”
22:33
Microsoft offers voluntary departures to approximately 60,000 employees across four countries amid massive investments in artificial intelligence
See more news